Literature DB >> 29654475

NMR comparison of hyphal and yeast Candida albicans serotype B mannans.

Peter Bystrický1, Eva Machová2, Slavomír Bystrický2.   

Abstract

A change from a globular to a filamentous hyphal form is an important feature in the pathogenicity of yeasts. Such a dimorphism while infecting a host organism is thought to be also accompanied in the case of Candida albicans spp. by a structural rearrangement of surface mannan antigen. The presented work brings new insights into the molecular structural changes of mannan C. albicans serotype B based on NMR experimental data. 1H and 13C signal identification of the anomeric region and the assignment of their linkage type is presented here. 2D deconvolution of the HSQC spectra facilitated accurate integration of all anomeric cross-peaks. Analysis of the differences in the integrals led to the proposal that C. albicans serotype B hyphal mannan side chains have the shortened structural moieties: Manα1-2Manα1- and Manα1-3 [Manα1-6] Manα1-2Manα1-. These represent the dominant structures important for construction of a saccharide-based prospective anti-candida vaccine.

Entities:  

Keywords:  Candida albicans; Hyphae; Mannan; NMR; Serotype A; Serotype B; Yeast

Mesh:

Substances:

Year:  2018        PMID: 29654475     DOI: 10.1007/s00249-018-1298-y

Source DB:  PubMed          Journal:  Eur Biophys J        ISSN: 0175-7571            Impact factor:   1.733


  10 in total

Review 1.  Immunological basis of anti-Candida vaccines focused on synthetically prepared cell wall mannan-derived manno-oligomers.

Authors:  Lucia Paulovičová; Ema Paulovičová; Slavomír Bystrický
Journal:  Microbiol Immunol       Date:  2014-10       Impact factor: 1.955

2.  Mannoproteins from yeast and hyphal form of Candida albicans considerably differ in mannan and protein content.

Authors:  Eva Machová; Lucia Fiačanová; Alžbeta Čížová; Jana Korcová
Journal:  Carbohydr Res       Date:  2015-03-10       Impact factor: 2.104

3.  Suppression of phase and amplitude J(HH) modulations in HSQC experiments.

Authors:  Laura Castañar; Eduard Sistaré; Albert Virgili; R Thomas Williamson; Teodor Parella
Journal:  Magn Reson Chem       Date:  2014-10-03       Impact factor: 2.447

Review 4.  Is a vaccine needed against Candida albicans?

Authors:  A Brian Mochon; Jim E Cutler
Journal:  Med Mycol       Date:  2005-03       Impact factor: 4.076

5.  Protective effect of the yeast glucomannan against cyclophosphamide-induced mutagenicity.

Authors:  D Chorvatovicová; E Machová; J Sandula; G Kogan
Journal:  Mutat Res       Date:  1999-07-21       Impact factor: 2.433

6.  Chemical structure of the cell-wall mannan of Candida albicans serotype A and its difference in yeast and hyphal forms.

Authors:  Nobuyuki Shibata; Akifumi Suzuki; Hidemitsu Kobayashi; Yoshio Okawa
Journal:  Biochem J       Date:  2007-06-15       Impact factor: 3.857

7.  A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection.

Authors:  Y Han; R P Morrison; J E Cutler
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  Temperature-dependent change of serological specificity of Candida albicans NIH A-207 cells cultured in yeast extract-added Sabouraud liquid medium: disappearance of surface antigenic factors 4, 5, and 6 at high temperature.

Authors:  Y Okawa; T Takahata; M Kawamata; M Miyauchi; N Shibata; A Suzuki; H Kobayashi; S Suzuki
Journal:  FEBS Lett       Date:  1994-05-30       Impact factor: 4.124

9.  Effect of branched α-oligomannoside structures on induction of anti-Candida humoral immune response.

Authors:  L Paulovičová; E Paulovičová; A A Karelin; Y E Tsvetkov; N E Nifantiev; S Bystrický
Journal:  Scand J Immunol       Date:  2013-06       Impact factor: 3.487

10.  Existence of branched side chains in the cell wall mannan of pathogenic yeast, Candida albicans. Structure-antigenicity relationship between the cell wall mannans of Candida albicans and Candida parapsilosis.

Authors:  N Shibata; K Ikuta; T Imai; Y Satoh; R Satoh; A Suzuki; C Kojima; H Kobayashi; K Hisamichi; S Suzuki
Journal:  J Biol Chem       Date:  1995-01-20       Impact factor: 5.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.